FDA to appeal judgement in Tobinco case

The Food and Drugs Authority (FDA) has expressed its displeasure with the court ruling awarding a judgement debt against the Authority to Tobinco Pharmaceutical Limited.

The protracted legal dispute ended last month with a GH¢93,905,760.79 judgment debt awarded to Tobinco Pharmaceutical Limited.

The company filed a suit against the FDA in 2019 after the Authority destroyed products belonging to Tobinco after it accused the company of bringing in counterfeit goods into the country.

Following the judgement, reports have suggested that the FDA failed to mount a strong defense in court leading to its loss of the suit.

However, the Authority in a statement issued on August 15 disagreed with claims of being unable to present a strong defense in court.

It asserted that despite the allegations against former CEO Dr Stephen Opuni by Tobinco Pharmaceuticals Ltd. the current leadership of FDA provided a robust defence at all material times during the court proceedings.

““The FDA acknowledges the judgment delivered by the High Court. However, the Authority respectfully disagrees with the decision and intends to exercise its right to appeal.

“The FDA remains committed to upholding the judicial process and adhering to the rule of law and will follow due process until the matter is fully resolved.”

Tobinco Pharmaceuticals Limited (TPL) and its Group Chairman, Elder Dr Samuel Amo Tobbin, were cleared of allegations of importing fake drugs into Ghana.

This ruling, delivered by Her Ladyship Audrey Kocuvie-Tay at the High Court, Accra, on July 29, 2024, was against claims made by former Chief Executive Officer of the Food and Drugs Authority (FDA), Dr Stephen Kwabena Opuni that the company had imported fake products into the country.

The post FDA to appeal judgement in Tobinco case first appeared on 3News.

Read Full Story